首页> 外文期刊>Pathology oncology research: POR >Elevated osteopontin expression and proliferative/apoptotic ratio in the colorectal adenoma-dysplasia-carcinoma sequence.
【24h】

Elevated osteopontin expression and proliferative/apoptotic ratio in the colorectal adenoma-dysplasia-carcinoma sequence.

机译:大肠腺瘤-不典型增生-癌序列中骨桥蛋白的表达和增殖/凋亡比率升高。

获取原文
获取原文并翻译 | 示例
           

摘要

Colorectal cancer progression is characterized by altered epithelial proliferation and apoptosis and by changed expression of tumor development regulators. Our aims were to determine the proliferative/apoptotic epithelial cell ratio (PAR) in the adenoma-dysplasia-carcinoma sequence (ADCS), and to examine its association with osteopontin (OPN), a previously identified protein product related to cancer development. One mm diameter cores from 13 healthy colons, 13 adenomas and 13 colon carcinoma samples were included into a tissue microarray (TMA) block. TUNEL reaction and Ki-67 immunohistochemistry were applied to determine the PAR. The osteopontin protein was also immunodetected. Stained slides were semiquantitatively evaluated using digital microscope and statistically analyzed with logistic regression and Fisher's exact test. The PAR continuously increased along the ADCS. It was significantly (p < 0.001) higher in cancer epithelium (8.84 +/- 7.01) than in adenomas (1.40 +/- 0.78) and in normal controls (0.89 +/- 0.21) (p < 0.001). Also, significant positive correlation was observed between elevated PAR and the expression of osteopontin. Cytoplasmic OPN expression was weak in healthy samples. In contrast, cytoplasmic immunoreaction was moderately intensive in adenomas, while in colon cancer strong, diffuse cytoplasmic immune staining was detected. Increasing PAR and OPN expression along ADCS may help monitoring colorectal cancer progression. The significantly elevated OPN protein levels we found during normal epithelium to carcinoma progression may contribute to the increased fibroblast-myofibroblast transition determining stem cell niche in colorectal cancer.
机译:大肠癌进展的特征在于改变的上皮增殖和凋亡以及改变的肿瘤发展调节剂的表达。我们的目标是确定腺瘤-异型增生-癌序列(ADCS)中的增殖/凋亡上皮细胞比例(PAR),并检查其与骨桥蛋白(OPN)的关联,骨桥蛋白(OPN)是先前鉴定的与癌症发展相关的蛋白质产品。将来自13个健康结肠,13个腺瘤和13个结肠癌样品的直径为1毫米的核心放入组织微阵列(TMA)块中。应用TUNEL反应和Ki-67免疫组化法测定PAR。骨桥蛋白也被免疫检测。使用数字显微镜对染色的载玻片进行半定量评估,并通过逻辑回归和Fisher精确检验进行统计学分析。 PAR沿ADCS连续增加。癌上皮(8.84 +/- 7.01)显着(p <0.001)高于腺瘤(1.40 +/- 0.78)和正常对照(0.89 +/- 0.21)(p <0.001)。另外,在升高的PAR与骨桥蛋白的表达之间观察到显着的正相关。在健康样品中细胞质OPN表达较弱。相比之下,腺瘤中的细胞质免疫反应中等强度,而在结肠癌中则检测到强烈的弥散性细胞质免疫染色。沿ADCS增加PAR和OPN表达可能有助于监测结肠直肠癌的进展。我们在正常上皮细胞向癌进展期间发现的OPN蛋白水平显着升高,这可能有助于决定大肠癌干细胞生态位的成纤维细胞-成肌纤维细胞过渡增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号